The NKV-440 offers invasive ventilation, non-invasive ventilation, and high-flow oxygen therapy in a single device.
RT’s Three Key Takeaways:
- NKV-440 Ventilator System Availability: Nihon Kohden America has made the FDA-cleared NKV-440 ventilator system available to a wider range of healthcare providers.
- Versatile Respiratory Support: The system combines invasive ventilation, non-invasive ventilation, and high-flow oxygen therapy in a single, compact device.
- Cost-Efficient Design: The NKV-440 operates without wall air or compressors and is designed for easy transport within healthcare settings.
Nihon Kohden America announced the availability of the US Food and Drug Administration-cleared NKV-440 ventilator system.
Previously offered through Nihon Kohden’s subsidiary, OrangeMed, this ventilator is now accessible to a wider range of healthcare providers.
The NKV-440 ventilator system is designed to meet the challenges healthcare facilities face today, such as staff shortages, budget constraints, and the need for adaptable, high-performance medical equipment, according to a release from the company.
“Healthcare providers need reliable, easy-to-use ventilators that can handle various patient needs without the need to switch devices,” says Roy Sakai, president of Nihon Kohden America, in a release. “The NKV-440 offers comprehensive respiratory support in one compact, portable unit.”
The NKV-440 ventilator system provides:
- All-in-One Care: Combines invasive ventilation, non-invasive ventilation, and high-flow oxygen therapy in a single device.
- Flexibility and Cost Efficiency: Operates without wall air or costly compressors, thanks to its turbine-driven design. Its compact size supports easy transport within the hospital, ensuring continuous respiratory support. This design also reduces maintenance requirements, making it a more cost-effective solution, according to a release from the company.
- Intuitive Design: Features a customizable, app-based touchscreen interface that is easy to learn and use.
“The NKV-440 ventilator has been a valuable addition to our respiratory solutions portfolio,” says Hong-Lin Du, MD, president of Nihon Kohden OrangeMed, in a release. “We’re excited to collaborate with Nihon Kohden America to bring this innovative ventilator to a broader market, ensuring more healthcare providers have access to this feature-rich solution.”
Photo caption: NKV-440 ventilator being used for invasive ventilation
Photo credit: Nihon Kohden
